• Saturday, Dec 10, 2022
  • Last Update : 10:24 am

Study: Sinopharm vaccine over 90% effective at preventing hospitalization

  • Published at 04:15 pm April 29th, 2021
Sinopharm vaccine
File photo of the Covid-19 vaccine made by the Beijing Institute of Biological Products, a unit of Sinopharm subsidiary China National Biotec Group (CNBG), taken on April 15, 2021 Reuters

The researchers found that the majority of people infected after receiving the vaccine reported mild symptoms and did not require treatment in hospital

A study conducted in Abu Dhabi has claimed that the Covid-19 vaccine developed by China’s Sinopharm is more than 90% effective at keeping patients out of hospitals.

None of the recipients of both doses of the vaccine died, while a significant decrease in the rate of new Covid-19 infections was recorded in the study, according to UAE media.

The researchers found that the majority of people infected after receiving the vaccine reported mild symptoms and did not require treatment in hospital.

The vaccine was 93% effective in preventing hospitalization and 95% effective against admission to intensive care, according to the study conducted by the Abu Dhabi Public Health Centre.

However, the authorities did not disclose how many people participated in the study or when the study was conducted.


Also Read- Bangladesh approves China’s Sinopharm Covid-19 vaccine for emergency use


Bangladesh on Thursday approved the Sinopharm vaccine for emergency use.

A shipment of 500,000 doses of vaccine would arrive in the country in two weeks as gifts, said Mahbubur Rahman, Director General, Directorate General of Drug Administration (DGDA).

The UAE study noted that people needed to continue following health safety guidelines even after receiving vaccines to restrict the spread of the virus.

The researchers said the chance of getting infected increased as the virus mutated, and that the chances of the virus mutating increased with its spread.

Additionally, the infection may lead to long-term health complications. The study found that post-Covid-19 syndrome might affect some senior citizens, people with chronic diseases and even healthy individuals.

Bangladesh has been administering the Covid-19 vaccine developed by Oxford University and AstraZeneca, which is 76% effective at preventing symptomatic illness.

Meanwhile, another Covid-19 vaccine developed by the US pharmaceutical company Pfizer Inc. has shown a more than 95% efficacy rate.

50
Facebook 50
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail